These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Hemochromatosis--from an underdiagnosed curiosity to a common disease]. Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085 [TBL] [Abstract][Full Text] [Related]
7. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
8. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. Loréal O; Gosriwatana I; Guyader D; Porter J; Brissot P; Hider RC J Hepatol; 2000 May; 32(5):727-33. PubMed ID: 10845658 [TBL] [Abstract][Full Text] [Related]
9. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron. Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219 [TBL] [Abstract][Full Text] [Related]
10. Screening for iron overload and HFE mutations in a university hospital. Remacha AF; Carrasco M; Sardà MP; Barceló MJ; Blesa I; Baiget M Haematologica; 2000 Aug; 85(8):873-4. PubMed ID: 10942939 [No Abstract] [Full Text] [Related]
11. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Bassett ML; Halliday JW; Ferris RA; Powell LW Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616 [TBL] [Abstract][Full Text] [Related]
13. [Practical use of genetic markers other than C282Y in iron overload disorders]. Brissot P Gastroenterol Clin Biol; 2002 Nov; 26(11):991-3. PubMed ID: 12483130 [No Abstract] [Full Text] [Related]
14. Iron overload without the C282Y mutation in patients with epilepsy. Ikeda M J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):551-3. PubMed ID: 11254788 [TBL] [Abstract][Full Text] [Related]
15. Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families. Muir WA; McLaren GD; Braun W; Askari A Am J Med; 1984 May; 76(5):806-14. PubMed ID: 6720728 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and diagnostic testing for hemochromatosis and iron overload. Adams PC Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957 [TBL] [Abstract][Full Text] [Related]
18. Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study. Harrison HF; Harrison BW; Walker AP; Lohman K; Ellis SD; Hall MA; Reiss J; Adams PC; Holup J; Acton RT; Bent T; Rivers C; Fadojutimi-Akinsiku M Genet Test; 2008 Dec; 12(4):491-500. PubMed ID: 18939938 [TBL] [Abstract][Full Text] [Related]
19. Why there is discordance in reported decision thresholds for transferrin saturation when screening for hereditary hemochromatosis. McCullen MA; Crawford DH; Dimeski G; Tate J; Hickman PE Hepatology; 2000 Dec; 32(6):1410-1. PubMed ID: 11186869 [No Abstract] [Full Text] [Related]
20. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Townsend A; Drakesmith H Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]